X-154706415-CAAAA-CAAAAAA
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_001081573.3(GAB3):c.1069+5812_1069+5813dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001081573.3 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001081573.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAB3 | MANE Select | c.1069+5812_1069+5813dupTT | intron | N/A | NP_001075042.1 | Q8WWW8-2 | |||
| GAB3 | c.1066+5812_1066+5813dupTT | intron | N/A | NP_542179.1 | Q8WWW8-1 | ||||
| GAB3 | c.1069+5812_1069+5813dupTT | intron | N/A | NP_001269212.1 | Q8WWW8-3 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GAB3 | TSL:1 MANE Select | c.1069+5813_1069+5814insTT | intron | N/A | ENSP00000399588.2 | Q8WWW8-2 | |||
| GAB3 | TSL:1 | c.1066+5813_1066+5814insTT | intron | N/A | ENSP00000358588.3 | Q8WWW8-1 | |||
| GAB3 | TSL:1 | n.617-6357_617-6356insTT | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 11AN: 93546Hom.: 0 Cov.: 0 show subpopulations
GnomAD4 genome AF: 0.000118 AC: 11AN: 93544Hom.: 0 Cov.: 0 AF XY: 0.0000971 AC XY: 2AN XY: 20606 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.